Role of Pentoxifylline and Celecoxib in Parkinsonism
Trial
Phase 2
Completed
Aug. 11, 2025
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
Trial
Phase 4
Recruiting
Aug. 11, 2025
Physiological Brain Atlas Development
Trial
N/A
Recruiting
Aug. 11, 2025
Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease
Trial
Phase 1
Completed
Aug. 10, 2025
Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
Trial
N/A
Not yet recruiting
Aug. 10, 2025
Cognitive Training in Parkinson's Disease
Trial
N/A
Completed
Aug. 10, 2025
A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease
Trial
N/A
Completed
Aug. 7, 2025
Autoimmune Features of Neurodegenerative Disorders
Trial
N/A
Recruiting
Aug. 7, 2025
Neuroplasticity in Parkinson's Disease
Trial
N/A
Recruiting
Aug. 7, 2025
New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients
Trial
N/A
Active, not recruiting
Aug. 7, 2025
Impact of a Biophoton Therapy on Patients With Brain Disorders
Trial
N/A
Recruiting
Aug. 7, 2025
Adhesion and Safety of Rotigexole Compared to Neupro®
Trial
N/A
Not yet recruiting
Aug. 6, 2025
The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease
Trial
N/A
Recruiting
Aug. 6, 2025
Saliva and Extracellular Vesicles for Neurodegenerative Diseases
Trial
N/A
Recruiting
Aug. 6, 2025
Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease
Trial
N/A
Recruiting
Aug. 6, 2025
Earlier Diagnosis and Better Treatment Mission Related to the Cohort Programme
Trial
N/A
Recruiting
Aug. 5, 2025
Quantitation of Glymphatic Functioning in Sleep and Meditative States
Trial
N/A
Completed
Aug. 5, 2025
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Trial
Phase 2
Terminated
Aug. 5, 2025
Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna
Trial
N/A
Recruiting
Aug. 5, 2025
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Trial
Phase 2
Terminated
Aug. 5, 2025